CNCR vs. BMED ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to BlackRock Future Health ETF (BMED)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$14.11

Average Daily Volume

45,400

Number of Holdings *

71

* may have additional holdings in another (foreign) market
BMED

BlackRock Future Health ETF

BMED Description The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$24.03

Average Daily Volume

1,216

Number of Holdings *

9

* may have additional holdings in another (foreign) market
Performance
Period CNCR BMED
30 Days -12.90% -7.59%
60 Days -13.54% -6.90%
90 Days 5.93% -0.49%
12 Months 11.10% -0.82%
0 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in BMED Overlap
CNCR Overweight 71 Positions Relative to BMED
Symbol Grade Weight
GERN A 2.62%
ACRV B 2.52%
ELVN B 2.3%
JANX A 1.83%
NUVB B 1.75%
TSVT F 1.68%
PRLD B 1.68%
RVMD A 1.48%
NRIX B 1.47%
ITOS D 1.46%
LYEL B 1.45%
GLUE B 1.44%
ACET F 1.43%
FHTX D 1.41%
HCM A 1.4%
MGNX B 1.4%
MRK A 1.39%
STRO F 1.37%
AURA F 1.35%
RAPT F 1.35%
EXEL A 1.34%
MOR A 1.34%
SDGR F 1.32%
INBX C 1.32%
YMAB B 1.32%
GMAB D 1.3%
VOR F 1.3%
DAWN B 1.3%
CGEM D 1.3%
PGEN F 1.3%
BPMC C 1.29%
IPHA F 1.28%
ERAS F 1.28%
BCYC B 1.27%
SNDX D 1.27%
BNTX F 1.26%
REGN C 1.25%
DCPH D 1.25%
ZNTL F 1.25%
IGMS F 1.23%
IMCR D 1.23%
BMY F 1.23%
MRUS D 1.23%
IDYA D 1.23%
XNCR F 1.22%
DNA F 1.19%
RCUS F 1.18%
KYMR D 1.16%
KPTI F 1.15%
KURA D 1.15%
IMTX D 1.15%
SWTX D 1.14%
AUTL D 1.14%
TYRA D 1.11%
RLAY F 1.11%
IOVA D 1.11%
ACLX D 1.09%
REPL F 1.07%
ALLO F 1.05%
FATE D 1.04%
LEGN F 1.04%
NUVL D 1.03%
ARVN D 1.03%
SMMT D 1.02%
MRSN D 1.01%
CRBU F 1.01%
BMEA F 0.99%
RXRX F 0.96%
IMRX F 0.88%
RPTX F 0.88%
GNLX F 0.81%
CNCR Underweight 9 Positions Relative to BMED
Symbol Grade Weight
COR B -3.21%
BSX A -3.07%
ISRG C -2.3%
ALGN B -2.24%
COO D -2.23%
WST B -2.21%
ABBV B -2.11%
AMGN B -1.88%
BMRN B -1.77%
Compare ETFs